Flush with $165M IPO cash, Zen­tal­is en­tices Ty­bourne, Or­biMed to fund a $20M Chi­na joint ven­ture

6 years ago
Financing

FDA, Ae­tion part­ner on re­al-world da­ta an­a­lyt­ics for Covid-19

6 years ago
FDA+
Coronavirus

As­traZeneca, Mer­ck push block­buster fran­chise to an­oth­er key FDA ap­proval, rel­e­gat­ing a ri­val to sec­ond-fid­dle sta­tus

6 years ago
Pharma
FDA+

Al­ly Bridge joins Bain in $120M bet that speed­ing up man­u­fac­tur­ing QC can hit big in post-pan­dem­ic world

6 years ago
Financing
Outsourcing

How a Cal­i­for­nia biotech briefly tripled its val­ue by hyp­ing a Covid-19 ‘cure’

6 years ago
R&D
Coronavirus

No­var­tis taps Iya Khalil, physi­cist co-founder of GNS Health­care, to lead AI In­no­va­tion Cen­ter

6 years ago
People
AI

Kin­tor Phar­ma­ceu­ti­cals com­pletes $240 mil­lion IPO; WuXi Bi­o­log­ics is open­ing a Boston plant

6 years ago
News Briefing

'Tis the sea­son for bio­phar­ma fundrais­ing, as Cowen clos­es $493M fund

6 years ago
Financing

BAR­DA of­fers a tiny start­up up to $812M to cre­ate a US-based drug man­u­fac­tur­er — and the CEO comes with a price ...

6 years ago
Startups
Deals

With bucks from Pfiz­er added to their new round, Am­plyx steers a tricky course through PhII and a glob­al pan­dem­ic

6 years ago
Financing
R&D

Covid-19 roundup: Trump says he's been tak­ing hy­drox­y­chloro­quine for days; Mod­er­na rais­es $1.3B on the heels of ...

6 years ago
Coronavirus

GSK sub’s in­jectable out­per­forms Gilead in late-stage PrEP tri­al

6 years ago
R&D

Mar­tin Mack­ay’s rare dis­ease start­up gets $145 mil­lion as it en­ters the clin­ic

6 years ago
Financing
Startups

Years af­ter Keytru­da, Roche's Tecen­triq monother­a­py wins first-line NSCLC ap­proval. So does it mat­ter?

6 years ago
R&D
FDA+

FDA up­dates Covid-19 clin­i­cal tri­als guid­ance to ad­dress se­ri­ous ad­verse events

6 years ago
FDA+
Coronavirus

Roche’s James Sabry ze­roes in on a new path­way for pro­tein degra­da­tion — and he’s pay­ing $135M cash for a hot ...

6 years ago
Deals

Two years in, Hong Kong’s biotech ex­per­i­ment has been val­i­dat­ed

6 years ago
Financing
China

SEC backs Sino­vac's case against ac­tivist in­vestor who tried to take over; Blue­bird pen­cils in $400M raise

6 years ago
News Briefing

Swe­den's Cal­lid­i­tas seeks $75M IPO haul to bring its oral steroid to pa­tients with an or­phan kid­ney dis­ease

6 years ago
Financing

J&J posts a sol­id round of pos­i­tive ear­ly da­ta for their BC­MA/CD3 bis­pe­cif­ic teclis­tam­ab, high­light­ing block­buster ...

6 years ago
R&D

As­traZeneca nabs break­through sta­tus, as $7B ADC races to block­buster sta­tus

6 years ago
R&D
FDA+

Oblit­er­at­ed by Alzheimer's fail­ure, Neu­rotrope re­lin­quish­es its Nas­daq spot in re­verse merg­er

6 years ago
Deals

Bob Langer-found­ed cell ther­a­py play­er loads up $65M to fund Roche-part­nered can­cer work while ex­pand­ing in­to ...

6 years ago
Financing
Cell/Gene Tx

Mod­er­na posts a promis­ing snap­shot of hu­man da­ta for a lead­ing Covid-19 vac­cine — and ral­ly makes Bob Langer a ...

6 years ago
R&D
Coronavirus
First page Previous page 841842843844845846847 Next page Last page
A service from the Financial Times